14.45
0.00
(0.00%)
May 20 - Close
NASDAQ
real-time data -
Disclaimer
Currency in USD
| Range | 14.10 - 14.63 |
| 52 week | 6.65 - 14.63 |
| Open | 14.22 |
| Vol / Avg. | 0.00/131,297.00 |
| Mkt cap | 374.68M |
| P/E | 18.31 |
| Div/yield | - |
| EPS | 0.79 |
| Shares | 25.93M |
| Beta | 0.92 |
| Inst. own | 85% |
Events
Jul 31, 2013
Q4 2013 Landec Corporation Earnings Release
Mar 27, 2013
Q3 2013 Landec Corporation Earnings Conference Call
Mar 27, 2013
Q3 2013 Landec Corporation Earnings Release
Mar 19, 2013
Landec Corporation at Roth Conference
|
More events from DailyFinance »
|
Key stats and ratios
| Q1 (Feb '13) | 2012 | |
| Net profit margin | 4.07% | 4.12% |
| Operating margin | 5.65% | 4.59% |
| EBITD margin | - | 6.81% |
| Return on average assets | 6.85% | 5.41% |
| Return on average equity | 11.33% | 8.88% |
| Employees | 532 | - |
| Carbon Disclosure Rating | - | - |
Address
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
Landec Corporation (Landec) designs, develops, manufactures and sells polymer products for food and agricultural products, medical devices and licensed partner applications that incorporate Landec's polymer technologies. The Company has two polymer technology platforms: Intelimer polymers, and hyaluronan (HA) biopolymers. The Intelimer polymer is a crystalline, hydrophobic polymer. Hyaluronan is a non-crystalline, hydrophilic polymer. Landec operates in four business segments: Apio, Inc. (Apio) with the Food Products Technology and Food Export businesses, Lifecore Biomedical, Inc., with the HA Biomaterials business and Landec's Technology Licensing business. On April 23, 2012, Apio acquired GreenLine Holding Company (GreenLine). On June 24, 2012, the Company sold Landec Ag LLC to INCOTEC Holding North America, Inc.
Officers and directors
| Gary T. Steele | Chairman of the Board, President, Chief Executive Officer | |
| Gregory S. Skinner | Chief Financial Officer, Vice President - Finance and Administration | |
| Nicholas Tompkins | Chairman of the Board of Apio, Inc., Director | |
| Damian A. Hajduk Ph.D. | Chief Scientific Officer | |
| Dennis J. Allingham | Vice President | |
| Steven P. Bitler Ph.D. | Vice President - Corporate Technology | |
| Ronald Lane Midyett | Vice President; President, Chief Executive Officer of Apio, Inc. | |
| Molly A. Hemmeter | Chief Commercial Officer | |
| Stephen E. Halprin | Lead Independent Director | |
| Duke K. Bristow Ph.D. | Independent Director |